BASSETTI, MATTEO
 Distribuzione geografica
Continente #
NA - Nord America 27.518
AS - Asia 8.062
EU - Europa 5.736
SA - Sud America 1.324
Continente sconosciuto - Info sul continente non disponibili 1.260
AF - Africa 167
OC - Oceania 7
Totale 44.074
Nazione #
US - Stati Uniti d'America 27.268
SG - Singapore 3.653
CN - Cina 1.688
UA - Ucraina 1.379
IT - Italia 1.120
BR - Brasile 1.029
HK - Hong Kong 877
DE - Germania 765
SE - Svezia 653
VN - Vietnam 640
TR - Turchia 489
RU - Federazione Russa 370
FR - Francia 325
IE - Irlanda 277
FI - Finlandia 252
GB - Regno Unito 219
IN - India 166
AR - Argentina 110
BD - Bangladesh 109
NL - Olanda 90
CA - Canada 86
MX - Messico 83
IQ - Iraq 58
JP - Giappone 54
AT - Austria 50
CO - Colombia 46
EC - Ecuador 46
PL - Polonia 44
ZA - Sudafrica 44
BE - Belgio 38
PK - Pakistan 37
ID - Indonesia 32
ES - Italia 31
SA - Arabia Saudita 30
EU - Europa 25
KR - Corea 24
UZ - Uzbekistan 24
VE - Venezuela 24
PH - Filippine 23
CL - Cile 22
CZ - Repubblica Ceca 21
KE - Kenya 20
PE - Perù 20
JO - Giordania 19
MA - Marocco 19
JM - Giamaica 16
CR - Costa Rica 14
MY - Malesia 14
RS - Serbia 14
TH - Thailandia 14
AE - Emirati Arabi Uniti 13
PY - Paraguay 13
AZ - Azerbaigian 12
IR - Iran 11
TN - Tunisia 11
BO - Bolivia 10
DZ - Algeria 10
LT - Lituania 10
DO - Repubblica Dominicana 9
KZ - Kazakistan 9
NP - Nepal 9
RO - Romania 9
CH - Svizzera 8
ET - Etiopia 8
HU - Ungheria 8
AO - Angola 7
DK - Danimarca 7
GT - Guatemala 7
LV - Lettonia 7
OM - Oman 7
EG - Egitto 6
IL - Israele 6
LB - Libano 6
NI - Nicaragua 6
AM - Armenia 5
BG - Bulgaria 5
GH - Ghana 5
GR - Grecia 5
HN - Honduras 5
PA - Panama 5
PT - Portogallo 5
TT - Trinidad e Tobago 5
KG - Kirghizistan 4
NZ - Nuova Zelanda 4
SK - Slovacchia (Repubblica Slovacca) 4
SV - El Salvador 4
AL - Albania 3
AU - Australia 3
BW - Botswana 3
CY - Cipro 3
GE - Georgia 3
LK - Sri Lanka 3
MM - Myanmar 3
MN - Mongolia 3
MZ - Mozambico 3
NG - Nigeria 3
SY - Repubblica araba siriana 3
TW - Taiwan 3
UY - Uruguay 3
BA - Bosnia-Erzegovina 2
Totale 42.777
Città #
Fairfield 3.666
Woodbridge 3.349
Houston 2.262
Ashburn 2.133
Ann Arbor 1.933
Singapore 1.541
Seattle 1.471
Chandler 1.364
Wilmington 1.313
Cambridge 1.303
Hong Kong 859
Dearborn 815
Beijing 750
Jacksonville 690
Izmir 453
Boardman 441
San Jose 438
Council Bluffs 412
Princeton 300
Dublin 274
Lauterbourg 270
Los Angeles 209
Udine 190
San Diego 175
Des Moines 166
Dong Ket 158
Ho Chi Minh City 157
Dallas 145
Redondo Beach 118
Milan 116
Buffalo 114
Hanoi 110
Santa Clara 103
Falls Church 94
São Paulo 89
New York 86
Andover 74
Hefei 68
Frankfurt am Main 67
Norwalk 65
Munich 63
Nanjing 55
Rome 54
Ogden 51
Helsinki 50
Phoenix 50
The Dalles 49
Tokyo 47
Guangzhou 40
Kunming 40
Chicago 38
Warsaw 38
Brussels 37
Orem 37
Nuremberg 35
Rio de Janeiro 34
Shanghai 34
Atlanta 33
Redmond 32
Brooklyn 30
Chennai 30
Grafing 30
Trieste 30
Jinan 28
London 27
Fuzhou 26
Montreal 26
Naples 26
Baghdad 25
Denver 24
Johannesburg 24
Mexico City 24
Vienna 24
Belo Horizonte 23
Haiphong 23
Mumbai 21
Turin 21
Amsterdam 20
Bologna 20
Fremont 20
Quito 20
Toronto 20
Curitiba 19
Da Nang 19
San Francisco 19
Stockholm 19
Tashkent 19
Boston 18
Palermo 18
Redwood City 18
Amman 17
Nanchang 17
Venezia 17
Zhengzhou 17
Brasília 16
Brno 16
Buenos Aires 16
Dhaka 16
Wuhan 16
Istanbul 15
Totale 30.032
Nome #
Terapia e profilassi delle infezioni 478
A regional approach to Antimicrobial Stewardship: the Friuli Venezia Giulia program 283
Impact of neuraminidase inhibitors on influenza A(H1N1)pdm09-related pneumonia: An individual participant data meta-analysis 269
Incidence and factors associated with the risk of sexually transmitted diseases in HIV-infected people seen for care in Italy: Data from the Icona Foundation cohort 253
Exploring ecological modelling to investigate factors governing the colonization success in nosocomial environment of Candida albicans and other pathogenic yeasts 250
The management of multidrug-resistant enterobacteriaceae 248
Antibiotic-resistant Pseudomonas aeruginosa: Focus on care in patients receiving assisted ventilation 245
Might real-time pharmacokinetic/pharmacodynamic optimisation of high-dose continuous-infusion meropenem improve clinical cure in infections caused by KPC-producing Klebsiella pneumoniae? 229
Delafloxacin for the treatment of respiratory and skin infections 224
A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational experts. 222
Ceftolozane/tazobactam for the treatment of MDR Pseudomonas aeruginosa left ventricular assist device infection as a bridge to heart transplant 215
Adherence to international and national recommendations for the prevention of surgical site infections in Italy: Results from an observational prospective study in elective surgery 214
Infections caused by KPC-producing Klebsiella pneumoniae: Differences in therapy and mortality in a multicentre study 206
Management of reduced vaccine coverage due to 6 years of failure to vaccinate: The Codroipo case, Italy 205
Antibiotic stewardship challenges in the management of community-acquired infections for prevention of escalating antibiotic resistance 202
"Excess mortality" and colistin-tigecycline for extensively drug-resistant Acinetobacter baumannii bacteremia 196
Risk factors for carbapenem-resistant Klebsiella pneumoniae bloodstream infection among rectal carriers: A prospective observational multicentre study 195
Gitelman syndrome disclosed by calcium pyrophosphate deposition disease: Early diagnosis by ultrasonographic study 192
A multicenter multinational study of abdominal candidiasis: epidemiology, outcomes and predictors of mortality 191
Management of carbapenem resistant Klebsiella pneumoniae infections in stem cell transplant recipients: An italian multidisciplinary consensus statement 189
Ceftolozane/tazobactam for the treatment of serious P. aeruginosa infections: a multicenter nationwide clinical experience 188
Task force on management and prevention of Acinetobacter baumannii infections in the ICU 186
Advances in antibiotic therapy in the critically ill 186
Characteristics of staphylococcus aureus bacteraemia and predictors of early and late mortality 185
Antiretroviral blood levels in HIV/HCV-coinfected patients with cirrhosis after liver transplant: A report of three cases 184
Ceftolozane/tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing urinary tract and intraabdominal infections in Europe: report from an antimicrobial surveillance programme (2012-15) 184
Evolution of HIV-1 tropism at quasispecies level after 5 years of combination antiretroviral therapy in patients always suppressed or experiencing episodes of virological failure 184
New therapeutic options for respiratory tract infections 182
Safety of long-term use of linezolid: Results of an open-label study 181
Ceftolozane/tazobactam: place in therapy 181
An Italian consensus for invasive candidiasis management (ITALIC) 181
Linezolid underexposure in a hypothyroid patient on levothyroxine replacement therapy: A case report 180
Year in review in Intensive Care Medicine 2013: II. Sedation, invasive and noninvasive ventilation, airways, ARDS, ECMO, family satisfaction, end-of-life care, organ donation, informed consent, safety, hematological issues in critically ill patients 179
18F-Fluorodeoxyglucose positron emission tomography and infectious diseases: current applications and future perspectives 179
Clinical efficacy of β-lactam/β-lactamase inhibitor combinations for the treatment of bloodstream infection due to extended-spectrum β-lactamaseproducing Enterobacteriaceae in haematological patients with neutropaenia: A study protocol for a retrospective observational study (BICAR) 179
Diagnosis and management of invasive candidiasis in the ICU: An updated approach to an old enemy 179
Persistent viremia and urine shedding of tick-borne encephalitis virus in an infected immunosuppressed patient from a new epidemic cluster in North-Eastern Italy 178
Is prolonged infusion of piperacillin/tazobactam and meropenem in critically ill patients associated with improved pharmacokinetic/pharmacodynamic and patient outcomes? An observation from the Defining Antibiotic Levels in Intensive care unit patients (DALI) cohort 178
Hot topics in necrotising skin and soft tissue infections 178
Different miRNA expression in transplanted livers of HCV mono-infected and HCV/HIV co-infected recipients 178
Impact of new treatment options for hepatitis c virus infection in liver transplantation 178
DALI: Defining antibiotic levels in intensive care unit patients: Are current ß-lactam antibiotic doses sufficient for critically ill patients? 176
Association between source control and mortality in 258 patients with intra-abdominal candidiasis: a retrospective multi-centric analysis comparing intensive care versus surgical wards in Spain 176
Community-acquired Legionella Pneumonia in the intensive care unit: Impact on survival of combined antibiotic therapy 176
Anidulafungin for the treatment of candidaemia caused by Candida parapsilosis: Analysis of pooled data from six prospective clinical studies 176
Clinical and pharmacokinetic drug evaluation of delafloxacin for the treatment of acute bacterial skin and skin structure infections 176
Current and future therapies for invasive aspergillosis 175
Risk factors and mortality of healthcare-associated and community-acquired Staphylococcus aureus bacteraemia 175
Resistance mechanisms and epidemiology of multiresistant pathogens in europe and efficacy of tigecycline in observational studies 175
Tick-borne encephalitis in North-East Italy: A 14-year retrospective study, January 2000 to December 2013 175
Variable incidence of candidemia in patients admitted to ICUs or medical wards of large tertiary-care Italian hospitals 175
Current and future treatment options for infections caused by multidrug-resistant Gram-negative pathogens 174
Year in review in Intensive Care Medicine 2014: III. Severe infections, septic shock, healthcare-associated infections, highly resistant bacteria, invasive fungal infections, severe viral infections, Ebola virus disease and paediatrics 174
Characteristics of an ideal nebulized antibiotic for the treatment of pneumonia in the intubated patient 174
Efficacy of tigecycline for the treatment of complicated intraabdominal infections in real-life clinical practice from five european observational studies 171
Risk factors associated with the onset of daptomycin non-susceptibility in Staphylococcus aureus infections in critically ill patients 171
Diagnosis and management of skin and soft-tissue infections (SSTI). A literature review and consensus statement: an update 171
Serological and T Cell Responses after Varicella Zoster Virus Vaccination in HIV-Positive Patients Undergoing Renal Dialysis 171
Year in review in Intensive Care Medicine 2013: III. Sepsis, infections, respiratory diseases, pediatrics 171
Management of intra-abdominal infections: recommendations by the Italian council for the optimization of antimicrobial use 170
Focus on antimicrobial use in the era of increasing antimicrobial resistance in ICU 170
Is first-line antimicrobial therapy still adequate to treat MRSA in the ICU? A report from a highly endemic country 170
A survey on infection management practices in Italian ICUs 170
Might isoniazid plasma exposure be a valuable predictor of drug-related hepatotoxicity risk among adult patients with TB? 170
A multicenter study of septic shock due to candidemia: outcomes and predictors of mortality 169
Focus on optimization of early antimicrobial therapy in ICU-acquired infections 168
New therapeutic options for skin and soft tissue infections 168
The role of methicillin-resistant Staphylococcus aureus in skin and soft tissue infections 168
Variability in protein binding of teicoplanin and achievement of therapeutic drug monitoring targets in critically ill patients: Lessons from the DALI Study 168
Linezolid underexposure in a patient co-treated with venlafaxine 167
Recurrent seizures during acute acquired toxoplasmosis in an immunocompetent traveller returning from Africa 167
Efficacy of intravenous cyclosporine in a case of cytophagic histiocytic panniculitis complicated by haemophagocytic syndrome after visceral leishmania infection 167
Infections caused by KPC-producing Klebsiella pneumoniae: Differences in therapy and mortality in a multicentre study-authors' response 166
Critically ill migrants with infection: diagnostic considerations for intensive care physicians in Europe 166
Critical issues for Klebsiella pneumoniae KPC-carbapenemase producing K. pneumoniae infections: A critical agenda 166
How Should We Treat HAP/VAP Caused by Carbapenemase-Producing Enterobacteriaceae? 166
Risk Factors and Outcomes of Infections by Multidrug-Resistant Gram-Negative Bacteria in Patients Undergoing Hematopoietic Stem Cell Transplantation 165
Global survey on nebulization of antimicrobial agents in mechanically ventilated patients: A call for international guidelines 165
Eravacycline for the treatment of intra-abdominal infections 165
The role of dalbavancin in skin and soft tissue infections 165
Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: A meta-analysis of individual participant data 164
Development of novel antibacterial drugs to combat multiple resistant organisms 164
Epidemiology, species distribution, antifungal susceptibility, and outcome of Candidemia across five sites in Italy and Spain 164
Infezioni delle vie urinarie: appropriatezza in antibioticoterapia 163
Epidemiology and predictors of recurrence of Clostridium difficile infection in a North Italian tertiary care hospital 162
First report of endocarditis by Gluconobacter spp. in a patient with a history of intravenous-drug abuse 162
Determination of PCT on admission is a useful tool for the assessment of disease severity in travelers with imported Plasmodium falciparum malaria 162
Successful and safe long-term treatment of cerebral aspergillosis with high-dose voriconazole guided by therapeutic drug monitoring 162
Intensive care unit patients with lower respiratory tract nosocomial infections: The ENIRRIs project 161
"Salvage treatment" for infections by extensively- and pan-drug-resistant pathogens is common and often sub-optimal 160
Treatment of Candida Infections with Fluconazole in Adult Liver Transplant Recipients: Is TDM-guided Dosing Adaptation Helpful? 160
Predicting the occurrence of embolic events: An analysis of 1456 episodes of infective endocarditis from the Italian Study on Endocarditis (SEI) 159
Independent risk factors for mortality in critically ill patients with candidemia on Italian Internal Medicine Wards 159
Evaluation of the prognostic value of impaired renal function on clinical progression in a large cohort of HIV-infected people seen for care in Italy 159
Fungal endogenous endophthalmitis secondary to magnusiomyces capitatus 159
Linezolid-resistant staphylococcal bacteraemia: A multicentre case-case-control study in Italy 159
Predictive models for identification of hospitalized patients harboring KPC-producing klebsiella pneumoniae 158
Prosthetic joints: Shining lights on challenging blind spots 158
Does contemporary vancomycin dosing achieve therapeutic targets in a heterogeneous clinical cohort of critically ill patients? Data from the multinational DALI study 158
An Evaluation of the Effectiveness of Risk Minimization Measures for Tigecycline in the European Union 157
Totale 18.372
Categoria #
all - tutte 152.534
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 152.534


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.413 0 0 223 157 55 197 219 104 49 443 502 464
2022/20233.147 340 150 42 411 353 902 1 230 524 35 77 82
2023/2024829 160 103 40 22 188 73 33 42 84 34 14 36
2024/20254.553 137 357 226 220 138 259 221 354 565 405 457 1.214
2025/20268.542 646 908 680 665 1.424 888 1.165 304 542 647 433 240
2026/20271.208 268 688 252 0 0 0 0 0 0 0 0 0
Totale 44.074